Royalty Pharma plc (RPRX)
USD 24.47
(-2.59%)
USD 24.47
(-2.59%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 3.03 Billion | 2.14 Billion | 2.01 Billion | 2.03 Billion | 1.66 Billion | 1.61 Billion |
| Net Income | 1.13 Billion | 230.06 Million | 1.24 Billion | 1.7 Billion | 2.46 Billion | 1.51 Billion |
| Depreciation & Amortization | 20.49 Million | 5.67 Million | 22.99 Million | 23.05 Million | 23.92 Million | 33.26 Million |
| Deferred income taxes | - | - | -1.52 Billion | 65.49 Million | - | - |
| Stock-based compensation | 2.35 Million | 2.17 Million | 2.44 Million | 5.42 Million | - | - |
| Change in working capital | 3.2 Billion | 32.66 Million | -16.32 Million | -1.88 Billion | -1.67 Billion | -1.56 Billion |
| Other non-cash items | -1.31 Billion | 1.87 Billion | 2.28 Billion | 2.12 Billion | 855.4 Million | 1.62 Billion |
| Investing Cash Flow | -2.1 Billion | -1.02 Billion | -1.87 Billion | -2.75 Billion | -2.11 Billion | 303.42 Million |
| Investments in PPE | -2.11 Billion | 2.04 Billion | 523 Thousand | 2.19 Billion | -1.72 Billion | 269.59 Million |
| Acquisitions | 12.44 Million | -9.89 Million | -34.85 Million | -40 Million | -27.04 Million | -24.17 Million |
| Investment purchases | -12.54 Million | -2.56 Billion | -3.59 Billion | -3.93 Billion | -2.36 Billion | -422.4 Million |
| Sales/Maturities of investments | 25.83 Million | 1.54 Billion | 1.77 Billion | 1.2 Billion | 524.55 Million | 750 Million |
| Other Investing Activities | -14.43 Million | -2.04 Billion | -18.6 Million | -2.18 Billion | 1.47 Billion | -269.59 Million |
| Financing Cash Flow | -2.16 Billion | -944.85 Million | 385.11 Million | 1.48 Billion | -1.19 Billion | -1.37 Billion |
| Debt repayment | -1 Billion | - | -1.25 Billion | -11.21 Billion | -294 Million | -294 Million |
| Dividends payments | -358.32 Million | -333.32 Million | -285.18 Million | -397.84 Million | -739.27 Million | -814.35 Million |
| Common Stock Repurchased | -304.75 Million | - | - | 11.89 Billion | -4.26 Million | - |
| Common Stock Issuance | -1.59 Million | - | - | 1.9 Billion | 4.26 Million | - |
| Other Financing Activities | -496.52 Million | -611.53 Million | 1.92 Billion | -706 Million | -158.35 Million | -270.74 Million |
| Accounts receivables | 1.06 Million | 31.71 Million | -29.14 Million | -400 Thousand | 159.86 Million | 111.52 Million |
| Accounts payables | 6.23 Million | 2.28 Million | -4.58 Million | -766 Thousand | 6.49 Million | 1.35 Million |
| Inventory | - | -31.71 Million | 29.14 Million | 400 Thousand | -166.35 Million | - |
| Other working capital | 3.19 Billion | 30.37 Million | -11.73 Million | -1.88 Billion | -1.67 Billion | -1.56 Billion |
| Cash at beginning of period | 1.71 Billion | 1.54 Billion | 1 Billion | 246 Million | 1.92 Billion | 1.38 Billion |
| Cash at end of period | 477.01 Million | 1.71 Billion | 1.54 Billion | 1 Billion | 283.68 Million | 1.92 Billion |
| Capital Expenditure | -2.11 Billion | 2.04 Billion | 523 Thousand | 2.19 Billion | -1.72 Billion | 269.59 Million |
| Effect of forex changes on cash | - | - | - | 371 Thousand | - | - |
| Net cash flow / Change in cash | -1.23 Billion | 169.7 Million | 532.36 Million | 763 Million | -1.64 Billion | 542.64 Million |
| Free Cash Flow | 916.16 Million | 4.18 Billion | 2.01 Billion | 4.23 Billion | -54.05 Million | 1.88 Billion |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 102 Million | 4.77 Million | 1.13 Billion | 495 Million | 122.07 Million | 351.33 Million |
| Depreciation & Amortization | 4.55 Million | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 681 Thousand | 612 Thousand | 2.35 Million | 617 Thousand | 581 Thousand | 586 Thousand |
| Change in working capital | 719.45 Million | 715.45 Million | 3.2 Billion | 795.26 Million | -37.02 Million | 37.63 Million |
| Other non-cash items | -157.95 Million | -47.19 Million | -1.31 Billion | -513.59 Million | 487.88 Million | 218.26 Million |
| Investing Cash Flow | -895.94 Million | -90.18 Million | -2.1 Billion | -998.75 Million | -450.65 Million | -63.43 Million |
| Investments in PPE | -746.62 Million | -86.08 Million | -2.11 Billion | -1 Billion | -451.13 Million | -60.44 Million |
| Acquisitions | 1.17 Million | 1.42 Million | 12.44 Million | 6.07 Million | -3.98 Million | -2.98 Million |
| Investment purchases | -203.98 Million | -6.97 Million | -12.54 Million | -1.99 Million | -451.13 Million | -60.44 Million |
| Sales/Maturities of investments | 101.45 Million | 1.44 Million | 25.83 Million | 1.44 Million | 451.13 Million | 123.87 Million |
| Other Investing Activities | -47.96 Million | -88.09 Million | -14.43 Million | -2.03 Million | 4.45 Million | -63.43 Million |
| Financing Cash Flow | 1.15 Billion | -213.42 Million | -2.16 Billion | -237.97 Million | -1.35 Billion | -346.99 Million |
| Debt repayment | -1.46 Billion | - | -1 Billion | -350 Million | -1 Billion | - |
| Dividends payments | -94.94 Million | -93.8 Million | -358.32 Million | -89.33 Million | -89.75 Million | -90.6 Million |
| Common Stock Repurchased | -79.99 Million | - | -304.75 Million | -30.2 Million | -140.11 Million | -134.44 Million |
| Common Stock Issuance | - | - | -1.59 Million | 348.4 Million | 1 Billion | - |
| Other Financing Activities | -131.62 Million | -119.61 Million | -496.52 Million | -116.83 Million | -1.12 Billion | -121.94 Million |
| Accounts receivables | -1.35 Million | 178 Thousand | 1.06 Million | 1.26 Million | -2.68 Million | 3.21 Million |
| Accounts payables | -6000.00 | -3.61 Million | 6.23 Million | 4.58 Million | 3.78 Million | -888 Thousand |
| Inventory | - | - | - | -199 Thousand | 2.68 Million | -3.21 Million |
| Other working capital | 720.81 Million | 718.89 Million | 3.19 Billion | 789.41 Million | -40.81 Million | 38.52 Million |
| Cash at beginning of period | 843 Million | 477.01 Million | 1.71 Billion | 936.44 Million | 2.17 Billion | 1.97 Billion |
| Cash at end of period | 1.76 Billion | 843 Million | 477.01 Million | 477.01 Million | 936.44 Million | 2.17 Billion |
| Capital Expenditure | -746.62 Million | -86.08 Million | -2.11 Billion | -1 Billion | -451.13 Million | -60.44 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 921.64 Million | 365.99 Million | -1.23 Billion | -459.43 Million | -1.23 Billion | 197.38 Million |
| Free Cash Flow | -84.47 Million | 583.51 Million | 916.16 Million | -224.95 Million | 122.38 Million | 547.37 Million |
RADL3
AMC
WLE
000059
OAU
0K3S